Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 299

1.

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens.

Titeler M, Lyon RA, Glennon RA.

Psychopharmacology (Berl). 1988;94(2):213-6.

PMID:
3127847
[PubMed - indexed for MEDLINE]
2.

Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.

Titeler M, Lyon RA, Davis KH, Glennon RA.

Biochem Pharmacol. 1987 Oct 1;36(19):3265-71.

PMID:
3663239
[PubMed - indexed for MEDLINE]
3.

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis.

Sadzot B, Baraban JM, Glennon RA, Lyon RA, Leonhardt S, Jan CR, Titeler M.

Psychopharmacology (Berl). 1989;98(4):495-9.

PMID:
2505289
[PubMed - indexed for MEDLINE]
4.

Serotonin2 agonist administration down-regulates rat brain serotonin2 receptors.

Buckholtz NS, Zhou DF, Freedman DX.

Life Sci. 1988;42(24):2439-45.

PMID:
3374263
[PubMed - indexed for MEDLINE]
5.

3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.

Lyon RA, Davis KH, Titeler M.

Mol Pharmacol. 1987 Feb;31(2):194-9.

PMID:
3543649
[PubMed - indexed for MEDLINE]
6.

A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.

Glennon RA, Titeler M, Lyon RA.

Pharmacol Biochem Behav. 1988 Jul;30(3):597-601.

PMID:
3211969
[PubMed - indexed for MEDLINE]
7.

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.

Pierce PA, Peroutka SJ.

Psychopharmacology (Berl). 1989;97(1):118-22.

PMID:
2540505
[PubMed - indexed for MEDLINE]
8.

Antagonism of 5-hydroxytryptamine2 receptor-mediated phosphatidylinositol turnover by d-lysergic acid diethylamide.

Pierce PA, Peroutka SJ.

J Pharmacol Exp Ther. 1988 Dec;247(3):918-25.

PMID:
3204523
[PubMed - indexed for MEDLINE]
9.

LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.

Arvanov VL, Liang X, Russo A, Wang RY.

Eur J Neurosci. 1999 Sep;11(9):3064-72.

PMID:
10510170
[PubMed - indexed for MEDLINE]
10.

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Glennon RA, Titeler M, McKenney JD.

Life Sci. 1984 Dec 17;35(25):2505-11.

PMID:
6513725
[PubMed - indexed for MEDLINE]
11.

Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.

Sanders-Bush E, Burris KD, Knoth K.

J Pharmacol Exp Ther. 1988 Sep;246(3):924-8.

PMID:
2843634
[PubMed - indexed for MEDLINE]
12.

Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain.

Buckholtz NS, Zhou DF, Freedman DX, Potter WZ.

Neuropsychopharmacology. 1990 Apr;3(2):137-48.

PMID:
1969270
[PubMed - indexed for MEDLINE]
13.

LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.

Marek GJ, Aghajanian GK.

J Pharmacol Exp Ther. 1996 Sep;278(3):1373-82.

PMID:
8819525
[PubMed - indexed for MEDLINE]
14.

[3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.

Titeler M, Herrick K, Lyon RA, McKenney JD, Glennon RA.

Eur J Pharmacol. 1985 Oct 29;117(1):145-6. No abstract available.

PMID:
4085543
[PubMed - indexed for MEDLINE]
15.

Serotonin excitation of facial motoneurons: receptor subtype characterization.

Rasmussen K, Aghajanian GK.

Synapse. 1990;5(4):324-32.

PMID:
2360199
[PubMed - indexed for MEDLINE]
16.

(R)-(-)-[77Br]4-bromo-2,5-dimethoxyamphetamine labels a novel 5-hydroxytryptamine binding site in brain membranes.

Peroutka SJ, Hamik A, Harrington MA, Hoffman AJ, Mathis CA, Pierce PA, Wang SS.

Mol Pharmacol. 1988 Oct;34(4):537-42.

PMID:
3173334
[PubMed - indexed for MEDLINE]
17.

Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.

Sanders-Bush E, Breeding M.

Psychopharmacology (Berl). 1991;105(3):340-6.

PMID:
1665919
[PubMed - indexed for MEDLINE]
18.
19.

Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, -HT(2B) and 5-HT2C receptors.

Nelson DL, Lucaites VL, Wainscott DB, Glennon RA.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Jan;359(1):1-6.

PMID:
9933142
[PubMed - indexed for MEDLINE]
20.

Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.

Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH.

Psychopharmacology (Berl). 2005 Sep;181(3):496-503. Epub 2005 Oct 12.

PMID:
15983786
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk